Publications in collaboration with researchers from Hospital Universitario La Paz (26)

2024

  1. Miettinen and Nurminen score statistics revisited

    Journal of Biopharmaceutical Statistics

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

  2. Critical Care in SARS‐CoV‐2 Infected Pregnant Women: A Prospective Multicenter Study

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Association of ABO and Rh blood groups with obstetric outcomes in SARS-CoV-2 infected pregnancies: A prospective study with a multivariate analysis

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 264, pp. 41-48

  2. Impact of recommended maternal vaccination programs on the clinical presentation of sars-cov-2 infection: A prospective observational study

    Vaccines, Vol. 9, Núm. 1, pp. 1-10

  3. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

    Viruses, Vol. 13, Núm. 1

  4. Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study

    Fertility and Sterility, Vol. 116, Núm. 3, pp. 731-740

  5. Pregnancy Outcomes and SARS-CoV-2 Infection: The Spanish Obstetric Emergency Group Study

    Viruses, Vol. 13, Núm. 5

  6. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis

    BMC Pregnancy and Childbirth, Vol. 21, Núm. 1

2020

  1. Comments on “Two-tailed significance tests for 2 × 2 contingency tables: What is the alternative?” by Robin J Prescott Statistics in Medicine 2019;38:4264-4269

    Statistics in Medicine

2019

  1. Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy

    Oncologist, Vol. 24, Núm. 8, pp. e784-e792

  2. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma

    Theranostics, Vol. 9, Núm. 17, pp. 4946-4958

2017

  1. PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics

    Journal of Molecular Diagnostics, Vol. 19, Núm. 4, pp. 575-588

  2. Targeted sequencing reveals low-frequency variants in EPHA genes as markers of paclitaxel-induced peripheral neuropathy

    Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1227-1235

2015

  1. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients

    Journal of Medical Genetics, Vol. 52, Núm. 10, pp. 647-656

  2. Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations

    International Journal of Cancer, Vol. 137, Núm. 8, pp. 1870-1878

2013

  1. Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions

    American Journal of Pathology, Vol. 182, Núm. 2, pp. 350-362

  2. Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma

    Endocrine-Related Cancer, Vol. 20, Núm. 4, pp. 611-619

  3. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways

    Endocrine-Related Cancer, Vol. 20, Núm. 4, pp. 477-493